Building a Biologics Business from the Ground Up

Opublikowany: 27.07.2018

Hannes Teissl, CEO Biologics and Corporate Vice President of Polpharma Biologics, discusses how Polpharma established a fully integrated biologics business in the latest issue of Pharma’s Almanac. Learn more about the strategy behind our modular one-stop-shop model and how Polpharma Biologics is leveraging 80 years of experience to develop much needed biologic and biosimilar therapies.

Read full article here

written by: Polpharma Biologics

Współpracujmy, aby dostarczać wysokiej jakości leki biopodobne.

Skontaktuj się, aby uzyskać więcej informacji.